These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7860926)

  • 1. Selective downregulation of rat cardiac beta 1-adrenoceptors by cyclosporine A: prevention by diltiazem or angiotensin-converting enzyme inhibitors.
    Brodde OE; Adamczyk M; Busch F; Bossaller C; Duske E; Fleck E; Götze S; Auch-Schwelk W
    J Am Coll Cardiol; 1995 Mar; 25(3):761-7. PubMed ID: 7860926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of a low-protein diet and certain pharmaceutical agents on the course of ablation nephropathy in rats].
    Heller J; Cervenka L; Hellerová S
    Cas Lek Cesk; 1994 Jul; 133(14):429-33. PubMed ID: 8069900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
    Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
    J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
    Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
    Richter MH; Richter HR; Olbrich HG; Mohr FW
    Transpl Int; 2003 Jan; 16(1):26-32. PubMed ID: 12545338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium entry blockade may prevent cyclosporin A-induced hypersensitivity to angiotensin II and endothelial dysfunction in the rat aorta.
    Götze S; Auch-Schwelk W; Bossaller C; Thelen J; Fleck E
    Eur Heart J; 1993 Nov; 14 Suppl I():104-10. PubMed ID: 8293761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term cardiac effects of hypotensive agents in normotensive mature rats: comparison of beta-blocking agent and converting enzyme inhibition.
    Azizi M; Levy B; Salzmann JL; Cerol ML; Poitevin P; Ménard J; Michel JB
    J Cardiovasc Pharmacol; 1989 May; 13(5):691-701. PubMed ID: 2472516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters.
    Witte K; Schnecko A; Hauth D; Wirzius S; Lemmer B
    Br J Pharmacol; 1998 Nov; 125(5):1033-41. PubMed ID: 9846642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats.
    Azzadin A; Małyszko J; Małyszko JS; Tankiewicz A; Myśliwiec M; Buczko W
    Pol J Pharmacol; 2002; 54(5):469-73. PubMed ID: 12593533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation of plasma membrane beta-adrenoceptors in rat hearts using the tissue segment binding method.
    Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Muramatsu I
    Life Sci; 2006 Aug; 79(10):941-8. PubMed ID: 16725159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of adrenergic receptors during regression of cardiac hypertrophy.
    Matsui H; Makino N; Yano K; Nakanishi H; Hata T; Yanaga T
    J Hypertens; 1994 Dec; 12(12):1353-7. PubMed ID: 7706693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
    Qiu CB; Qiu CS; Hess P; Clozel JP; Clozel M
    Acta Pharmacol Sin; 2001 Jun; 22(6):541-8. PubMed ID: 11747762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on survival and cardiac remodeling in chronic heart failure in rats.
    Richer C; Fornes P; Domergue V; De Gasparo M; Giudicelli JF
    J Card Fail; 2001 Sep; 7(3):269-76. PubMed ID: 11561229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
    Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I
    Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype-selective modulation of human beta 1- and beta 2-adrenoceptor function by beta-adrenoceptor agonists and antagonists.
    Brodde OE; Daul A; Michel MC
    Clin Physiol Biochem; 1990; 8 Suppl 2():11-7. PubMed ID: 1982757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats.
    Seyfarth T; Gerbershagen HP; Giessler C; Leineweber K; Heinroth-Hoffmann I; Pönicke K; Brodde OE
    J Mol Cell Cardiol; 2000 Dec; 32(12):2315-26. PubMed ID: 11113007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.